top
Search terms
Results 1 - 3 of 3 - ordered by :
Epeuropace

Fibrosis is a major constituent of structural (and functional) remodelling and a convergent outcome of tissue reparative and reactive responses to inflammation, stretch, repetitive oxidative stress, ...

Europace, Review, Irene Savelieva, Nicholaos Kakouros, Antonios Kourliouros, A. John Camm

Date : 01/05/2011 Item size : 518680 bytes
Epeuropace

Vernakalant: 65 ± 11 Placebo: 66± 10 AF 3 h to 45 days AF 3 h to 7 days: n = 170 AF 845 days: n = 9 Atrial flutter: n = 23 Hypertension, 43.9% ischaemic heart disease, 11.8% myocardial ...

Europace, Review, Irene Savelieva, Richard Graydon, A. John Camm

Date : 01/02/2014
Epeuropace

Clinical trials comparing rate control with rhythm control Randomized trials comparing outcomes of rhythm vs. rate control strategies in patients with AF are summarized in Tables 13 and 14.8692 Among ...

Europace, ESC GUIDELINES, Developed with the special contribution of the European Heart Rhythm Association (EHRA), Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS), ...

Date : 01/10/2010